What is Bonesupport?
Headquartered in Sweden, Bonesupport AB is a specialized medical device company dedicated to the development and commercialization of orthobiologic solutions. The firm's core competency lies in its proprietary technology platform, which utilizes calcium sulfate and hydroxyapatite formulations to create injectable synthetic bone graft substitutes. These products are engineered to provide both structural support and biological integration, facilitating natural bone regeneration while gradually resorbing as the patient heals.
A key differentiator for Bonesupport is its dual-action approach, which combines bone void filling with local antibiotic delivery. This capability is particularly vital for treating challenging conditions such as osteomyelitis, where surgeons require both structural stability and infection management. By maintaining a strong focus on clinical evidence and scientific research, the company continues to set new standards of care in orthopedic and trauma surgery, effectively bridging the gap between traditional bone grafting and modern regenerative medicine.
How much funding has Bonesupport raised?
Bonesupport has raised a total of $256M across 5 funding rounds:
Unspecified
$15M
Unspecified
$120M
Unspecified
$70M
Private Equity
$14M
Private Equity
$37M
Unspecified (2006): $15M with participation from Teknoinvest, Ferd Venture, and Innovations Kapital
Unspecified (2011): $120M led by Industrifonden and HealthCap Partners
Unspecified (2012): $70M supported by Industrifonden, HealthCap Partners, and Lundbeckfond Ventures
Private Equity (2015): $14M, investors not publicly disclosed
Private Equity (2016): $37M backed by HealthCap Partners, Kreos Capital, Industrifonden, AP3, and Lundbeckfond Ventures
Key Investors in Bonesupport
Industrifonden
A Swedish venture capital fund that invests in unique, scalable innovations aimed at improving society through breakthrough technologies and science, with a focus on life sciences and deep tech.
HealthCap Partners
A private equity firm specializing in creative growth capital and real estate solutions for the strategic needs of the healthcare industry, with over $1.1 billion in sector investments.
Lundbeckfond Ventures
The venture arm of a commercial research foundation that awards grants to biomedical research groups, focusing on brain research and international biotech investments.
What's next for Bonesupport?
Looking ahead, the strategic deployment of the $37M is expected to accelerate Bonesupport's market penetration and support the ongoing expansion of its product portfolio. Given the company's established lifecycle stage, the focus will likely shift toward scaling commercial operations and deepening its footprint in international healthcare systems. The continued support from long-term institutional partners suggests a stable outlook for the company as it seeks to further integrate its bone healing solutions into standard orthopedic protocols globally.
The firm remains well-positioned to leverage its scientific expertise to address unmet needs in musculoskeletal trauma. As the company continues to prioritize clinical validation, it is poised to maintain its competitive advantage in the orthobiologics market, potentially exploring new applications for its antibiotic-eluting technology to further improve patient outcomes in complex surgical scenarios.
